Indicators

Latest News about Bristol/Myers Squibb Co

Recent news which mentions Bristol/Myers Squibb Co

< Previous 1 2 3 Next >

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

April 01, 2025

Cramer's Lightning Round: Deere is a buy

February 19, 2025

Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma

February 10, 2025

5 things to know before the stock market opens Thursday

February 06, 2025

Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance

February 06, 2025

5 things to know before the stock market opens Monday

February 03, 2025

Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

January 31, 2025

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

January 17, 2025

Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug

January 15, 2025

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

January 14, 2025

Bristol Myers Squibb CEO describes new drug for treating schizophrenia

January 13, 2025

Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market

January 08, 2025

Here are our top 10 things to watch in the stock market Monday

December 23, 2024

Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data

December 05, 2024

Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries

November 15, 2024

Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs

October 31, 2024

5 things to know before the stock market opens Monday

October 28, 2024

Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon

October 25, 2024

5 things to know before the stock market opens Friday

September 27, 2024

FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades

September 26, 2024

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

September 16, 2024

What's next for the Biden administration's Medicare drug price negotiations

August 15, 2024

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

August 06, 2024

Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs

July 26, 2024

Healthy Returns: The first round of Medicare drug price negotiations is nearing an end

July 23, 2024

5 things to know before the stock market opens Monday

July 22, 2024

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

June 28, 2024

Cramer's Lightning Round: 'I would not abandon' Cava

June 24, 2024

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big

June 07, 2024

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.